CVS Group (CVSG) Aktienübersicht
Die CVS Group plc ist zusammen mit ihren Tochtergesellschaften im Vereinigten Königreich und in Australien in den Bereichen Tiermedizin, Online-Apotheken und Einzelhandel tätig. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 3/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 2/6 |
| Finanzielle Gesundheit | 3/6 |
| Dividenden | 0/6 |
CVSG Community Fair Values
Create NarrativeSee what 24 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
CVS Group plc Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | UK£12.44 |
| 52-Wochen-Hoch | UK£16.48 |
| 52-Wochen-Tief | UK£10.62 |
| Beta | 1.06 |
| 1 Monat Veränderung | 0.16% |
| 3 Monate Veränderung | 10.87% |
| 1 Jahr Veränderung | 2.30% |
| 3 Jahre Veränderung | -35.71% |
| 5 Jahre Veränderung | -47.51% |
| Veränderung seit IPO | 444.42% |
Aktuelle Nachrichten und Updates
Narrativ-Update • Jun 24
CVSG: Share Buyback Momentum Will Support Future Upside Potential
Analysts have kept their fair value estimate for CVS Group steady at £16.40, with small adjustments to assumptions such as the discount rate and future P/E leading to only a marginal change in the overall price target narrative. What’s in the News for CVS Group CVS Group commenced a share repurchase program on May 26, 2026, committing up to £50 million to buy back its shares.Narrativ-Update • Jun 06
CVSG: Activist Buyback Push And Index Inclusion Will Support Future Upside
Analysts have kept their £16.40 fair value estimate for CVS Group broadly unchanged, with a slightly higher discount rate and modest tweaks to revenue growth, profit margin and future P/E assumptions helping to frame a neutral stance following recent Street research. What's in the News Converium Capital Inc.
Narrativ-Update • May 22
CVSG: Neutral Coverage And Buyback Pressure Will Shape Future Earnings Profile
Analysts have trimmed their fair value estimate for CVS Group from £14.20 to £13.40, citing a slightly higher discount rate, updated assumptions for revenue growth and profit margins, and a modestly lower future P/E multiple following recent neutral Street research coverage. Analyst Commentary Recent Street research has taken a more cautious stance on CVS Group, with neutral positioning reflecting a balance between the company’s potential and a set of clear execution and valuation questions.Narrativ-Update • May 01
CVSG: Neutral Initiation And Stable Assumptions Will Support Higher Future Price Objective
Analysts have kept their fair value estimate for CVS Group steady at £16.40, with only small tweaks to revenue growth and profit margin assumptions. This reflects a neutral stance following recent Street research initiation.Recent updates
Narrativ-Update • Jun 24
CVSG: Share Buyback Momentum Will Support Future Upside Potential
Analysts have kept their fair value estimate for CVS Group steady at £16.40, with small adjustments to assumptions such as the discount rate and future P/E leading to only a marginal change in the overall price target narrative. What’s in the News for CVS Group CVS Group commenced a share repurchase program on May 26, 2026, committing up to £50 million to buy back its shares.Narrativ-Update • Jun 06
CVSG: Activist Buyback Push And Index Inclusion Will Support Future Upside
Analysts have kept their £16.40 fair value estimate for CVS Group broadly unchanged, with a slightly higher discount rate and modest tweaks to revenue growth, profit margin and future P/E assumptions helping to frame a neutral stance following recent Street research. What's in the News Converium Capital Inc.Narrativ-Update • May 22
CVSG: Neutral Coverage And Buyback Pressure Will Shape Future Earnings Profile
Analysts have trimmed their fair value estimate for CVS Group from £14.20 to £13.40, citing a slightly higher discount rate, updated assumptions for revenue growth and profit margins, and a modestly lower future P/E multiple following recent neutral Street research coverage. Analyst Commentary Recent Street research has taken a more cautious stance on CVS Group, with neutral positioning reflecting a balance between the company’s potential and a set of clear execution and valuation questions.Narrativ-Update • May 01
CVSG: Neutral Initiation And Stable Assumptions Will Support Higher Future Price Objective
Analysts have kept their fair value estimate for CVS Group steady at £16.40, with only small tweaks to revenue growth and profit margin assumptions. This reflects a neutral stance following recent Street research initiation.Narrativ-Update • Apr 16
CVSG: Neutral Coverage And Steady Fundamentals Will Support Higher Future Price Objective
Analysts have maintained their fair value estimate for CVS Group at £16.40. This reflects a neutral recalibration of expectations that aligns with recent Street research highlighting a balanced risk and reward profile following the new coverage initiation.Narrativ-Update • Apr 02
CVSG: Neutral Coverage And Buybacks Will Support Higher Future Price Objective
Analysts have trimmed their fair value estimate for CVS Group from about £16.73 to roughly £16.40. This reflects slightly softer revenue growth assumptions, a modestly higher profit margin outlook and a small adjustment to the future P/E multiple following recent neutral coverage initiation.Narrativ-Update • Mar 19
CVSG: Completed Buyback And Margin Outlook Will Support A Stronger Future Earnings Profile
Analysts have kept their fair value estimate for CVS Group steady at £14.20. This reflects slightly lower assumed revenue growth, balanced by a modestly higher profit margin outlook and a small reduction in the future P/E multiple used in their models.Narrativ-Update • Mar 05
CVSG: Share Repurchase Completion Will Support Higher Future Price Objective
Analysts have inched their price target for CVS Group higher to £16.73 from £16.62, reflecting updated assumptions for fair value, discount rate, revenue growth and profit margins. What's in the News CVS Group completed a share buyback tranche, repurchasing 1,584,690 shares for £20 million, equal to 2.21% of its share capital, under the program announced on October 24, 2025 (Key Developments).Narrativ-Update • Feb 18
CVSG: Completed Buyback And Stable Assumptions Will Shape Balanced Near Term Outlook
Analysts have made only a marginal tweak to their fair value outlook for CVS Group, keeping the target around £14.20, as small adjustments to discount rate, revenue growth, profit margin and future P/E assumptions offset each other rather than driving a clear shift in valuation. What's in the News CVS Group completed a share buyback tranche, repurchasing 1,584,690 shares for £20 million, equal to 2.21% of the company.Narrativ-Update • Feb 04
CVSG: Completed Buyback And Steady Assumptions Will Support Balanced Near Term Returns
Analysts have nudged their price target on CVS Group slightly higher to reflect small updates to revenue growth and margin assumptions, while keeping fair value broadly unchanged in cash terms. What's in the News CVS Group completed a share buyback tranche covering 1,584,690 shares, representing 2.21% of the company, for a total of £20 million, under the programme announced on October 24, 2025 (Key Developments).Narrativ-Update • Jan 21
CVSG: Share Buyback And Steady Outlook Will Support Balanced Return Potential
Analysts have trimmed their price target on CVS Group to £14.20, citing slightly higher assumed revenue growth of 5.37% and a modestly stronger profit margin of 6.68%, offset by a marginally lower future P/E of 23.54x. What's in the News CVS Group plc has announced a share repurchase program of up to £20 million, with all repurchased ordinary shares to be cancelled as part of its capital allocation policy (Key Developments).Analyseartikel • Jan 10
CVS Group (LON:CVSG) Is Doing The Right Things To Multiply Its Share Price
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Narrativ-Update • Jan 07
CVSG: Higher Price Objective Will Be Supported By Share Repurchase Programme
Analysts have lifted their price target on CVS Group to £19.00 from £15.00, citing updated research that supports a higher valuation range for the shares. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a £19.00 price target as support for a higher valuation range, implying they view the current share price as not fully reflecting the company’s potential.Narrativ-Update • Dec 17
CVSG: Raised Share Price Outlook May Support Further Upside Potential
Analysts have raised their fair value estimate for CVS Group from approximately £12.50 to £14.20 per share, supported by higher Street price targets, including a recent increase to 1,900 GBp, even as they factor in a slightly higher discount rate and more moderate long term revenue growth and margins. Analyst Commentary While the latest price target increase to 1,900 GBp reflects growing confidence in the medium term trajectory, not all market observers are aligned with this more constructive outlook.Narrativ-Update • Dec 03
CVSG: Higher Price Objective Will Drive Returns Through Margin Expansion
Analysts have raised their price target for CVS Group to £19.00 from £15.00, reflecting improved expectations for profit margins and earnings sustainability, despite only minor adjustments to growth assumptions and valuation multiples. Analyst Commentary Analysts note that the higher price target reflects a more constructive view on the company’s execution and earnings profile, even as headline assumptions for top line expansion remain broadly unchanged.Narrativ-Update • Nov 19
CVSG: Outperform Rating Will Drive Shareholder Value With New Buyback Plan
Analysts have raised their price target for CVS Group shares from £15.00 to £19.00. They cite improved revenue growth and profit margin projections as factors supporting a more favorable outlook.Analyseartikel • Nov 10
At UK£12.08, Is CVS Group plc (LON:CVSG) Worth Looking At Closely?
While CVS Group plc ( LON:CVSG ) might not have the largest market cap around , it received a lot of attention from a...Narrativ-Update • Nov 04
CVSG: Shares Will Gain From Buyback Programme and Dividend Increase
The analyst price target for CVS Group has been raised by £4.00 per share to £19.00, as analysts highlight ongoing confidence in the company's outlook following recent adjustments to growth and profitability forecasts. Analyst Commentary Following the recent price target revision, analysts have provided a range of perspectives on the company’s valuation, execution, and growth outlook.Analyseartikel • Oct 24
Investors Appear Satisfied With CVS Group plc's (LON:CVSG) Prospects
With a price-to-earnings (or "P/E") ratio of 54.1x CVS Group plc ( LON:CVSG ) may be sending very bearish signals at...Narrativ-Update • Oct 21
Analysts Lift CVS Group Valuation Following Improved Growth and Dividend Announcement
Analysts have raised their price target for CVS Group from £15.44 to £16.43, citing improved revenue growth and profit margin expectations as key drivers for the upward revision. What's in the News The Board of CVS Group plc has recommended a final dividend payment of 8.5p per Ordinary share, an increase from 8.0p in 2024 (Key Developments).Analyseartikel • Oct 08
Is There An Opportunity With CVS Group plc's (LON:CVSG) 30% Undervaluation?
Key Insights The projected fair value for CVS Group is UK£19.70 based on 2 Stage Free Cash Flow to Equity CVS Group's...Analyseartikel • May 23
CVS Group plc's (LON:CVSG) P/E Is Still On The Mark Following 25% Share Price Bounce
CVS Group plc ( LON:CVSG ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...Analyseartikel • Mar 14
CVS Group plc (LON:CVSG) Shares Could Be 44% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, CVS Group fair value estimate is UK£17.41 CVS Group is...
Neues Narrativ • Feb 09
Australian Veterinary Expansion And Investments Will Create Future Opportunities
CVS Group's strategic expansions and acquisitions in Australia could drive future revenue growth and increased market share.Analyseartikel • Jan 30
Market Participants Recognise CVS Group plc's (LON:CVSG) Earnings Pushing Shares 26% Higher
CVS Group plc ( LON:CVSG ) shareholders would be excited to see that the share price has had a great month, posting a...Analyseartikel • Dec 04
CVS Group (LON:CVSG) Has A Somewhat Strained Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Oct 16
CVS Group plc's (LON:CVSG) Price In Tune With Earnings
With a price-to-earnings (or "P/E") ratio of 27.2x CVS Group plc ( LON:CVSG ) may be sending very bearish signals at...Analyseartikel • Sep 10
Should You Think About Buying CVS Group plc (LON:CVSG) Now?
CVS Group plc ( LON:CVSG ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...Analyseartikel • Jun 05
CVS Group (LON:CVSG) Is Doing The Right Things To Multiply Its Share Price
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analyseartikel • Mar 28
CVS Group (LON:CVSG) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Feb 29
CVS Group (LON:CVSG) Is Looking To Continue Growing Its Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...Analyseartikel • Feb 09
Getting In Cheap On CVS Group plc (LON:CVSG) Is Unlikely
When close to half the companies in the United Kingdom have price-to-earnings ratios (or "P/E's") below 15x, you may...Analyseartikel • Dec 11
Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
While CVS Group plc ( LON:CVSG ) might not be the most widely known stock at the moment, it saw a decent share price...Analyseartikel • Nov 23
Most Shareholders Will Probably Agree With CVS Group plc's (LON:CVSG) CEO Compensation
Key Insights CVS Group's Annual General Meeting to take place on 29th of November Salary of UK£430.0k is part of CEO...Analyseartikel • Nov 15
Is CVS Group (LON:CVSG) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyseartikel • Oct 27
CVS Group plc's (LON:CVSG) Intrinsic Value Is Potentially 89% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, CVS Group fair value estimate is UK£26.21 Current share price...Analyseartikel • Sep 23
Here's Why CVS Group (LON:CVSG) Has Caught The Eye Of Investors
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analyseartikel • Sep 08
CVS Group's (LON:CVSG) Returns On Capital Are Heading Higher
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analyseartikel • Jun 28
We Think CVS Group (LON:CVSG) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analyseartikel • May 25
Should You Investigate CVS Group plc (LON:CVSG) At UK£20.72?
CVS Group plc ( LON:CVSG ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...Analyseartikel • May 12
A Look At The Fair Value Of CVS Group plc (LON:CVSG)
Key Insights CVS Group's estimated fair value is UK£20.01 based on 2 Stage Free Cash Flow to Equity CVS Group's...Analyseartikel • Apr 15
Should You Be Adding CVS Group (LON:CVSG) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analyseartikel • Feb 01
A Look At The Fair Value Of CVS Group plc (LON:CVSG)
How far off is CVS Group plc ( LON:CVSG ) from its intrinsic value? Using the most recent financial data, we'll take a...Analyseartikel • Jan 05
Here's Why We Think CVS Group (LON:CVSG) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analyseartikel • Nov 30
Returns At CVS Group (LON:CVSG) Are On The Way Up
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...Aktionärsrenditen
| CVSG | GB Healthcare | GB Markt | |
|---|---|---|---|
| 7D | 5.7% | 2.5% | 1.9% |
| 1Y | 2.3% | -0.04% | 19.9% |
Rendite im Vergleich zur Industrie: CVSG übertraf die Branche UK Healthcare , die im vergangenen Jahr eine Rendite von -0 erzielte.
Rendite vs. Markt: CVSG hinter dem Markt UK zurück, der im vergangenen Jahr eine Rendite von 19.9 erzielte.
Preisvolatilität
| CVSG volatility | |
|---|---|
| CVSG Average Weekly Movement | 4.1% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in GB Market | 10.8% |
| 10% least volatile stocks in GB Market | 2.9% |
Stabiler Aktienkurs: CVSG hatte in den letzten 3 Monaten im Vergleich zum UK -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: CVSGDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1999 | 9,000 | Richard William Fairman | www.cvsukltd.co.uk |
Die CVS Group plc ist zusammen mit ihren Tochtergesellschaften im Vereinigten Königreich und in Australien in den Bereichen Tiermedizin, Online-Apotheken und Einzelhandel tätig. Das Unternehmen ist in den Segmenten Tierarztpraxen, Laboratorien und Online-Einzelhandel tätig. Das Unternehmen ist in Tierarztpraxen und ergänzenden veterinärmedizinischen Diagnostikgeschäften tätig.
CVS Group plc's Grundlagenzusammenfassung
| CVSG grundlegende Statistiken | |
|---|---|
| Marktanteil | UK£872.75m |
| Gewinn(TTM) | UK£16.50m |
| Umsatz(TTM) | UK£692.80m |
52.9x
Kurs-Gewinn-Verhältnis 1.3x
Kurs-Umsatz-VerhältnisIst CVSG zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| CVSG Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | UK£692.80m |
| Kosten der Einnahmen | UK£393.20m |
| Bruttogewinn | UK£299.60m |
| Sonstige Ausgaben | UK£283.10m |
| Gewinn | UK£16.50m |
Zuletzt gemeldete Gewinne
Dec 31, 2025
Datum des nächsten Gewinnberichts
Sep 24, 2026
| Gewinn per Aktie (EPS) | 0.24 |
| Bruttomarge | 43.24% |
| Nettogewinnspanne | 2.38% |
| Schulden/Eigenkapital-Verhältnis | 56.9% |
Wie hat sich CVSG auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
0.7%
Aktuelle Dividendenrendite37%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/06 14:48 |
| Aktienkurs zum Tagesende | 2026/07/03 00:00 |
| Gewinne | 2025/12/31 |
| Jährliche Einnahmen | 2025/06/30 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
CVS Group plc wird von 13 Analysten beobachtet. 9 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Sharanya Gajapathy | Barclays |
| James Bayliss | Berenberg |
| Allan Smylie | Davy |